Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Circulating methylated DNA.

James G Herman1

  • 1Department of Oncology, Evelyn Grollman Glick Scholar, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland 21231, USA. hermanji@jhmi.edu

Annals of the New York Academy of Sciences
|July 15, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Leveraging Commercially Available Protein Assays as Biomarkers for Lung Cancer.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same author

Lnc5q21.2, a novel long intergenic RNA, sensitizes colorectal cancer cells to ATR inhibitor by activating Wnt pathway.

Journal of translational internal medicine·2025
Same author

Randomized Phase II Clinical Trial of Sulforaphane in Former Smokers at High Risk for Lung Cancer.

Cancer prevention research (Philadelphia, Pa.)·2025
Same author

Multiplex digital profiling of DNA methylation heterogeneity for sensitive and cost-effective cancer detection in low-volume liquid biopsies.

Science advances·2024
Same author

Brief Report: Phase II Clinical Trial of Atezolizumab in Advanced Nonsmall Cell Lung Cancer Patients Previously Treated With PD-1-Directed Therapy.

Clinical lung cancer·2024
Same author

Neighborhood-level deprivation and survival in lung cancer.

BMC cancer·2024
Same journal

Multiomics Profiling During Autoimmune Demyelination Highlights a Complex Regulatory Role for Ataxin-1 in B Cells.

Annals of the New York Academy of Sciences·2026
Same journal

Global Trends in Light Pollution and Their Relationship With Socioeconomic Factors.

Annals of the New York Academy of Sciences·2026
Same journal

Wired for Corruption: Inter-Brain Synchrony Encodes Bribery-Related Value Information and Predicts Bribery Agreement.

Annals of the New York Academy of Sciences·2026
Same journal

LM-YOLO: A Lightweight Multi-Scale Enhanced Model for Forest Smoke Detection Using Unmanned Aerial Vehicles.

Annals of the New York Academy of Sciences·2026
Same journal

Polyrhythm Perception and Production: A Scoping Review.

Annals of the New York Academy of Sciences·2026
Same journal

DARTS-CNN-BiLSTM: Intelligent Fault Diagnosis for Computer Numerical Control Machine Tool Feed System.

Annals of the New York Academy of Sciences·2026
See all related articles

Early cancer detection is improved by analyzing circulating nucleic acids. DNA methylation in circulating DNA offers a stable, detectable biomarker for cancer progression and early diagnosis.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Early cancer detection significantly improves patient survival rates by enabling timely intervention.
  • Circulating nucleic acids in blood are promising biomarkers for non-invasive cancer detection and monitoring.
  • DNA methylation analysis offers a stable and sensitive approach for cancer biomarker discovery.

Purpose of the Study:

  • To explore the potential of circulating nucleic acids as biomarkers for early cancer detection.
  • To investigate DNA methylation as a specific nucleic acid-based marker for cancer.
  • To assess the advantages of DNA methylation for tracking cancer progression.

Main Methods:

  • Analysis of circulating nucleic acids in patient blood samples.

Related Experiment Videos

  • Utilizing DNA methylation patterns in CpG islands of gene promoter regions.
  • Employing polymerase chain reaction (PCR)-based techniques for detection.
  • Investigating the stability and preferential presence of methylated DNA in plasma/serum nucleosomes.

    • Main Results:

    • Demonstrated the presence and detectability of methylated DNA in bloodstream circulation.
    • Highlighted the stability of DNA as a reliable biomarker molecule.
    • Showcased the efficacy of PCR-based methods for identifying methylation changes.
    • Indicated the preferential association of methylated DNA with nucleosomes in plasma/serum.

    Conclusions:

    • Circulating methylated DNA is a viable biomarker for early cancer detection.
    • DNA methylation analysis presents a stable and accessible method for cancer diagnostics.
    • This approach holds potential for monitoring cancer progression and patient outcomes.